Is There an NP in the Rheum? The Role of NPs in Overcoming Underrecognition and Treatment Delays to Improve Patient Outcomes in Axial Spondyloarthritis (ID: i816b-3) Survey

1.How many years have you been in practice?(Required.)

>21

11-20

1-10

<1

2.How many patients with axSpA do you manage per week?  (Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

3.Please select the option that best describes your practice setting:(Required.)

Hospital Network

Institutional Setting (skilled-nursing facilities, correctional facilities, mental hospitals and psychiatric units)

Retail Pharmacy

Urgent Care

Private Practice

Group Practice

Other (please specify)

4.After participating in this activity, how confident are you in the management of patients with axSpA in your practice? (Required.)

5.How committed are you to making changes in your practice based on your participation in this activity?(Required.)

If not committed or do not plan to make changes, please indicate reason

6.Which of the following best describes the impact of this activity on your performance?(Required.)

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

7.Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.(Required.)

Improved ability to determine if a patient’s back pain is mechanical or might be inflammatory, caused by axSpA

Will consult and apply ASAS diagnostic criteria for each patient who presents with possible axSpA

A raised index of suspicion in women who present with peripheral involvement that may indicate axSpA

Will be alert for extra-articular manifestations that in addition to back pain, may be one of the first presenting symptoms of axSpA

Review and consider axSpA guidelines when considering treatment recommendations

Will evaluate clinical trial findings when considering treatments for patients with axSpA

8.What barriers do you see to making changes in your practice? Please select all that apply.(Required.)

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

12.Overall, was this activity fair and balanced (Required.)

Yes

No

If No, please explain:

13.As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

14.Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for axSpA:

15.If you indicated that you perceived commercial bias or influence, please describe: